DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways

BACKGROUND: The B-cell lymphoma 6 (BCL6) oncogene is required for the survival of diffuse large B-cell lymphoma (DLBCL), which is incurable using conventional chemotherapy. Thus, it is imperative to improve the survival of patients with DLBCL. Disulfide (DSF) has been shown to have anticancer effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yunying, Lei, Chenshuang, Jiang, Qian, Yu, Qinhua, Qiu, Liannv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317061/
https://www.ncbi.nlm.nih.gov/pubmed/35883106
http://dx.doi.org/10.1186/s12935-022-02661-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317061/
https://www.ncbi.nlm.nih.gov/pubmed/35883106
http://dx.doi.org/10.1186/s12935-022-02661-4

Ejemplares similares